These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 23364919)

  • 41. Density-Dependent Regulation of Glioma Cell Proliferation and Invasion Mediated by miR-9.
    Katakowski M; Charteris N; Chopp M; Khain E
    Cancer Microenviron; 2016 Dec; 9(2-3):149-159. PubMed ID: 27975329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-based screens for synthetic lethal interactions with c-Myc.
    Li Y; Zhu Y; Prochownik EV
    RNA Dis; 2016; 3(3):. PubMed ID: 27975083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis.
    Seashols-Williams SJ; Budd W; Clark GC; Wu Q; Daniel R; Dragoescu E; Zehner ZE
    PLoS One; 2016; 11(7):e0159601. PubMed ID: 27447934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. STARD13-correlated ceRNA network inhibits EMT and metastasis of breast cancer.
    Li X; Zheng L; Zhang F; Hu J; Chou J; Liu Y; Xing Y; Xi T
    Oncotarget; 2016 Apr; 7(17):23197-211. PubMed ID: 26985770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms.
    Teng Y; Li X
    Clin Exp Metastasis; 2014 Mar; 31(3):367-77. PubMed ID: 24158354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level.
    Wang Z; Liu M; Zhu H; Zhang W; He S; Hu C; Quan L; Bai J; Xu N
    Int J Oncol; 2010 Nov; 37(5):1315-21. PubMed ID: 20878079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
    Xiong J; Du Q; Liang Z
    Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
    Ma L; Young J; Prabhala H; Pan E; Mestdagh P; Muth D; Teruya-Feldstein J; Reinhardt F; Onder TT; Valastyan S; Westermann F; Speleman F; Vandesompele J; Weinberg RA
    Nat Cell Biol; 2010 Mar; 12(3):247-56. PubMed ID: 20173740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E; Crémisi C
    Oncogene; 1999 Oct; 18(41):5662-71. PubMed ID: 10523846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9.
    Lu MH; Huang CC; Pan MR; Chen HH; Hung WC
    Clin Cancer Res; 2012 Dec; 18(23):6416-25. PubMed ID: 23045246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-Myc suppressed E-cadherin through miR-9 at the post-transcriptional level.
    Liu M; Zhu H; Yang S; Wang Z; Bai J; Xu N
    Cell Biol Int; 2013 Mar; 37(3):197-202. PubMed ID: 23364919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting MYC in cancer therapy: RNA processing offers new opportunities.
    Koh CM; Sabò A; Guccione E
    Bioessays; 2016 Mar; 38(3):266-75. PubMed ID: 26778668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MYC and the art of microRNA maintenance.
    Psathas JN; Thomas-Tikhonenko A
    Cold Spring Harb Perspect Med; 2014 Apr; 4(8):. PubMed ID: 24737842
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.